英格兰髋部骨折后一年内再骨折、再手术和死亡的住院费用归因研究
本研究链接英国国家数据集,纳入2016年4月1日至2019年3月31日期间英格兰所有医院收治的年龄≥60岁髋部骨折手术患者共164,691例,随访一年。按再骨折、再手术和死亡组合分为八组,采用广义线性模型估算归因于并发症的额外住院费用。结果显示,再骨折和再手术患者费用约为无并发症者的两倍,并发症患者贡献了全国髋部骨折住院总支出的近一半。
要点
- 再骨折或再手术患者一年住院费用约为无并发症者的两倍。
- 再骨折合并再手术且死亡者额外费用最高,达+£16,971(95%CI 15,914–18,028)。
- 全国髋部骨折住院年支出£647百万,其中£265百万归因于并发症患者。
核心结论
- 髋部骨折后近一半全国住院支出集中于发生并发症或死亡的患者,再骨折和再手术显著增加住院费用,强调预防并发症和再骨折的重要性。
研究设计与样本
- 全国性队列研究,链接国家数据集识别2016年4月1日至2019年3月31日英格兰所有医院≥60岁髋部骨折手术患者,随访一年。
- 共纳入164,691例患者(70.8%女性,平均年龄82.7岁,SD 8.7),分布于159家医院。
- 按再骨折(指数骨折后30天以上、任何骨骼部位、排除面部/指/趾/颅骨骨折)、再手术和死亡组合分为八组,采用广义线性模型估算边际成本差异,费用按2019/20 NHS参考成本计算。
主要发现
- 患者一年平均住院费用为£14,581(SD 8,583)。
- 再骨折患者平均费用£24,306(SD 11,635,n=11,226),再手术患者£23,923(SD 13,537,n=7,522),无并发症患者£12,859(SD 7,097,n=107,638)。
- 调整前骨折费用、骨折类型和病例组合后,再骨折合并再手术且一年内死亡者额外费用最高(+£16,971,95%CI 15,914–18,028,n=541),其次为再骨折合并再手术存活者(+£13,562,95%CI 13,065–14,059,n=2,348),参照为无并发症存活者调整后费用(均值£13,159,95%CI 13,118–13,201)。
- 2018/19年英格兰髋部骨折住院年支出估计为£647百万,其中£265百万归因于并发症患者(占所有患者35%)。
临床怎么用
- 应重视髋部骨折后并发症预防,尤其是再骨折和再手术的防控,以降低住院费用负担。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Within one year after hip fracture in older adults living in England, this study aimed to estimate the inpatient hospital costs associated with subsequent complications, including further fractures, reoperations, and death. METHODS: The study linked national datasets to identify all patients aged ≥ 60 years who underwent an index hip fracture operation in all hospitals in England between 1 April 2016 and 31 March 2019, with one-year follow-up. Patients were categorized into eight mutually exclusive groups based on combinations of further fracture (after 30 days from index hip fracture, at any skeletal site, excluding facial, digit, and skull fractures), reoperation, and death in the year after hip fracture. Inpatient costs were valued using 2019/20 NHS reference costs. Marginal cost differences over patients with no complications were estimated using generalized linear models. RESULTS: Among 164,691 patients (70.8% female (n = 116,534); mean age 82.7 years (SD 8.7)), across 159 hospitals, the mean one-year inpatient cost was £14,581 (SD 8,583). Further fracture (£24,306 (SD 11,635); n = 11,226) and reoperation (£23,923 (SD 13,537); n = 7,522) were each associated with approximately twice the cost of patients without complications (£12,859 (SD 7,097); n = 107,638). Additional costs, adjusted for prefracture costs, fracture type, and patient case-mix variables, were highest for patients with further fracture and reoperation who died within one year (+£16,971 (95% CI 15,914 to 18,028); n = 541), closely followed by patients with both further fracture and reoperation who survived (+£13,562 (95% CI 13,065 to 14,059); n = 2,348), compared with adjusted cost of patients who survived with no complications (mean £13,159 (95% CI 13,118 to 13,201)). Nationally, annual inpatient expenditure for hip fracture care was estimated to £647 million in 2018/19. Of this, £265 million was attributable to patients with a complication (35% of all patients). CONCLUSION: Nearly half of total national inpatient expenditure on hip fracture care is concentrated among patients who experienced complications or died. Further fracture and reoperation markedly increase inpatient expenditure, highlighting the importance of preventing complications and refractures.
引用
- Baji P, Gregson CL, Patel R, et al. Hospital costs attributable to further fracture, reoperation, and death during the first year following hip fracture in England : a nationwide cohort study. Bone Joint J. 2026. PMID: 42379565. doi:10.1302/0301-620X.108B7.BJJ-2025-1758.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。